ADAM17 and chronic obstructive pulmonary disease: Moreover, CS‐induced ADAM17‐mediated shedding of IL6R and AREG is especially high in COPD ALI‐PBEC, suggesting that reducing ADAM17 activity in COPD might be a potential therapeutic approach.